DELIVERING INNOVATION. WHERE IT’S NEEDED.

Learn About PROPEL

Intersect ENT is defining and delivering novel treatments designed to transform the landscape of ENT care. We apply a focused, evidence-based approach to solve clinical challenges and improve the quality of life for patients.

PROPEL Contour Logo - Mometasone Furoate Sinus Drug Delivery Implant

For Use in the Frontal and Maxillary Sinus Ostia Following Sinus Surgery

Product
Details
Press
Release

For Physicians

Products designed to address clinical challenges and improving the quality of life for Chronic Sinusitis patients.
LEARN MORE

For Patients

Learn more about sinusitis and treatment options to open up, and keep open, the sinuses.
LEARN MORE

Our Technologies

Bioabsorbable platform technology that gradually delivers steroids directly where it is needed.
LEARN MORE

The PROPEL dissolvable steroid-releasing sinus implants are the only products backed by Level 1-A clinical evidence to improve surgical outcomes for chronic sinusitis sufferers.

Learn About PROPEL
PROPEL Logo - Mometasone Furoate Localized Sinus Drug Delivery

News & Press Releases

Intersect ENT Announces Presentation of a Meta-Analysis from Two Randomized Studies Evaluating the
Safety and Efficacy of SINUVA™, an Investigational Steroid Releasing Sinus Implant
Intersect ENT Announces PDUFA Date for Office-Based SINUVA Steroid Releasing Sinus Implant
Intersect ENT Announces Positive Clinical Results of Pivotal Study of RESOLVE In-Office Steroid Releasing Implant
Intersect ENT Announces Publication of PROGRESS Study of Steroid Releasing Implant in Patients with Frontal Sinus Disease